Wegovy fuels sharp rise in use of weight-loss drugs for US youth
Public Health,Children,Obesity And Malnutrition
From the Center
AllSides Media Bias Rating: Center
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
News
What the Media Missed: Children Recovered, Heat Deaths Soared, and More
Malayna J. Bizier
September 12th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
Affordable Care Act
Headline Roundup
Amazon Announces $1 Billion for Communities Near Its Data Centers
October 3rd, 2026
